These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 34425463)

  • 21. Steroid protection in the experimental autoimmune encephalomyelitis model of multiple sclerosis.
    Garay L; Gonzalez Deniselle MC; Gierman L; Meyer M; Lima A; Roig P; De Nicola AF
    Neuroimmunomodulation; 2008; 15(1):76-83. PubMed ID: 18667803
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Riluzole suppresses experimental autoimmune encephalomyelitis: implications for the treatment of multiple sclerosis.
    Gilgun-Sherki Y; Panet H; Melamed E; Offen D
    Brain Res; 2003 Nov; 989(2):196-204. PubMed ID: 14556941
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NAD+ attenuates experimental autoimmune encephalomyelitis through induction of CD11b+ gr-1+ myeloid-derived suppressor cells.
    Wang JL; Li B; Tan GJ; Gai XL; Xing JN; Wang JQ; Quan MY; Zhang N; Guo L
    Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32301489
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-inflammatory, antioxidant and anti-mitophagy effects of trans sodium crocetinate on experimental autoimmune encephalomyelitis in BALB/C57 mice.
    Banaeeyeh S; Afkhami-Goli A; Moosavi Z; Razavi BM; Hosseinzadeh H
    Metab Brain Dis; 2024 Jun; 39(5):783-801. PubMed ID: 38739183
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inosine, an Endogenous Purine Nucleoside, Suppresses Immune Responses and Protects Mice from Experimental Autoimmune Encephalomyelitis: a Role for A2A Adenosine Receptor.
    Junqueira SC; Dos Santos Coelho I; Lieberknecht V; Cunha MP; Calixto JB; Rodrigues ALS; Santos ARS; Dutra RC
    Mol Neurobiol; 2017 Jul; 54(5):3271-3285. PubMed ID: 27130268
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systemic administration of orexin A ameliorates established experimental autoimmune encephalomyelitis by diminishing neuroinflammation.
    Becquet L; Abad C; Leclercq M; Miel C; Jean L; Riou G; Couvineau A; Boyer O; Tan YV
    J Neuroinflammation; 2019 Mar; 16(1):64. PubMed ID: 30894198
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of aqueous extract of Achillea millefolium on the development of experimental autoimmune encephalomyelitis in C57BL/6 mice.
    Vazirinejad R; Ayoobi F; Arababadi MK; Eftekharian MM; Darekordi A; Goudarzvand M; Hassanshahi G; Taghavi MM; Ahmadabadi BN; Kennedy D; Shamsizadeh A
    Indian J Pharmacol; 2014; 46(3):303-8. PubMed ID: 24987178
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sinomenine Alleviates Murine Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis through Inhibiting NLRP3 Inflammasome.
    Kiasalari Z; Afshin-Majd S; Baluchnejadmojarad T; Azadi-Ahmadabadi E; Fakour M; Ghasemi-Tarie R; Jalalzade-Ogvar S; Khodashenas V; Tashakori-Miyanroudi M; Roghani M
    J Mol Neurosci; 2021 Feb; 71(2):215-224. PubMed ID: 32812186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Scoring Central Nervous System Inflammation, Demyelination, and Axon Injury in Experimental Autoimmune Encephalomyelitis.
    Ucciferri CC; Gower A; Alvarez-Sanchez N; Whetstone H; Ramaglia V; Gommerman JL; Brand-Arzamendi K; Schneider R; Dunn SE
    J Vis Exp; 2024 Feb; (204):. PubMed ID: 38465945
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new formulation of cannabidiol in cream shows therapeutic effects in a mouse model of experimental autoimmune encephalomyelitis.
    Giacoppo S; Galuppo M; Pollastro F; Grassi G; Bramanti P; Mazzon E
    Daru; 2015 Oct; 23():48. PubMed ID: 26489494
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cathepsin C modulates myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis.
    Durose WW; Shimizu T; Li J; Abe M; Sakimura K; Chetsawang B; Tanaka KF; Suzumura A; Tohyama K; Ikenaka K
    J Neurochem; 2019 Feb; 148(3):413-425. PubMed ID: 30152001
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic effects of diosgenin in experimental autoimmune encephalomyelitis.
    Liu W; Zhu M; Yu Z; Yin D; Lu F; Pu Y; Zhao C; He C; Cao L
    J Neuroimmunol; 2017 Dec; 313():152-160. PubMed ID: 29132838
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bu Shen Yi Sui Capsule Alleviates Neuroinflammation and Demyelination by Promoting Microglia toward M2 Polarization, Which Correlates with Changes in miR-124 and miR-155 in Experimental Autoimmune Encephalomyelitis.
    Zha Z; Gao YF; Ji J; Sun YQ; Li JL; Qi F; Zhang N; Jin LY; Xue B; Yang T; Fan YP; Zhao H; Wang L
    Oxid Med Cell Longev; 2021; 2021():5521503. PubMed ID: 33815654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loss of Nrf2 exacerbates the visual deficits and optic neuritis elicited by experimental autoimmune encephalomyelitis.
    Larabee CM; Desai S; Agasing A; Georgescu C; Wren JD; Axtell RC; Plafker SM
    Mol Vis; 2016; 22():1503-1513. PubMed ID: 28050123
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gold nanoparticles and polyethylene glycol alleviate clinical symptoms and alter cytokine secretion in a mouse model of experimental autoimmune encephalomyelitis.
    Aghaie T; Jazayeri MH; Avan A; Anissian A; Salari AA
    IUBMB Life; 2019 Sep; 71(9):1313-1321. PubMed ID: 30957389
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The immunoregulatory and neuroprotective effects of human adipose derived stem cells overexpressing IL-11 and IL-13 in the experimental autoimmune encephalomyelitis mice.
    Azimzadeh M; Mahmoodi M; Kazemi M; Hakemi MG; Jafarinia M; Eslami A; Salehi H; Amirpour N
    Int Immunopharmacol; 2020 Oct; 87():106808. PubMed ID: 32693359
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distinct pathological patterns in relapsing-remitting and chronic models of experimental autoimmune enchephalomyelitis and the neuroprotective effect of glatiramer acetate.
    Aharoni R; Vainshtein A; Stock A; Eilam R; From R; Shinder V; Arnon R
    J Autoimmun; 2011 Nov; 37(3):228-41. PubMed ID: 21752599
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cannabidiol inhibits pathogenic T cells, decreases spinal microglial activation and ameliorates multiple sclerosis-like disease in C57BL/6 mice.
    Kozela E; Lev N; Kaushansky N; Eilam R; Rimmerman N; Levy R; Ben-Nun A; Juknat A; Vogel Z
    Br J Pharmacol; 2011 Aug; 163(7):1507-19. PubMed ID: 21449980
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ellagic acid ameliorates neuroinflammation and demyelination in experimental autoimmune encephalomyelitis: Involvement of NLRP3 and pyroptosis.
    Kiasalari Z; Afshin-Majd S; Baluchnejadmojarad T; Azadi-Ahmadabadi E; Esmaeil-Jamaat E; Fahanik-Babaei J; Fakour M; Fereidouni F; Ghasemi-Tarie R; Jalalzade-Ogvar S; Khodashenas V; Sanaierad A; Zahedi E; Roghani M
    J Chem Neuroanat; 2021 Jan; 111():101891. PubMed ID: 33217488
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ACT-1004-1239, a first-in-class CXCR7 antagonist with both immunomodulatory and promyelinating effects for the treatment of inflammatory demyelinating diseases.
    Pouzol L; Baumlin N; Sassi A; Tunis M; Marrie J; Vezzali E; Farine H; Mentzel U; Martinic MM
    FASEB J; 2021 Mar; 35(3):e21431. PubMed ID: 33595155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.